| Blalock-Taussig shunt | A palliative subclavian artery to pulmonary artery anastomosis. (05 Mar 2000) |
|---|---|
| Rapoport-Luebering shunt | Part of the glycolytic pathway characteristic of human erythrocytes in which 2,3-bisphosphoglycerate (2,3-P2Gri) is formed as an intermediate between 1,3-P2Gri and 3-phosphoglycerate; 2,3-P2Gri is an important regulator of the affinity of haemoglobin for oxygen. (05 Mar 2000) |
| ventriculoperitoneal shunt | <procedure> A surgical procedure to insert a communicating catheter to relieve intracranial pressure caused by hydrocephalus. In this procedure the cerebrospinal fluid is shunted from the ventricles of the brain into the peritoneal cavity via a surgically implanted tube. (27 Sep 1997) |
| Glenn shunt | A means of palliating cyanotic heart disease by anastomosing the right pulmonary artery to the superior vena cava. Synonym: cavopulmonary shunt, Glenn shunt. (05 Mar 2000) |
| cavopulmonary shunt | A means of palliating cyanotic heart disease by anastomosing the right pulmonary artery to the superior vena cava. Synonym: cavopulmonary shunt, Glenn shunt. (05 Mar 2000) |
| renal-splenic venous shunt | Anastomosis of the splenic vein to the left renal vein, usually end-to-side, for control of portal hypertension. Synonym: renal-splenic venous shunt. (05 Mar 2000) |
| vp shunt | <procedure> A surgical procedure to insert a communicating catheter to relieve intracranial pressure caused by hydrocephalus. In this procedure the cerebrospinal fluid is shunted from the ventricles of the brain into the peritoneal cavity via a surgically implanted tube. (27 Sep 1997) |
| pentose monophosphate shunt | <biochemistry> A pathway of hexose oxidation in which glucose-6-phosphate undergoes two successive oxidations by NADP, the final one being an oxidative decarboxylation to form a pentose phosphate. Diverges from this when glucose-6-phosphate is oxidized to ribose 5 phosphate by the enzyme glucose-6 phosphate dehydrogenase. This step reduces NADP to NADPH, generating a source of reducing power in cells for use in reductive biosyntheses. In plants, part of the pathway functions in the formation of hexoses from carbon dioxide in photosynthesis. Also important as source of pentoses, for example for nucleic acid biosynthesis. This pathway is the main metabolic pathway in neutrophils, congenital deficiency in the pathway produces sensitivity to infection. Alternative metabolic route to Embden Meyerhof pathway for breakdown of glucose. (18 Nov 1997) |
| reversed shunt | Right-to-left shunt that had previously been a left-to-right shunt; rarely the opposite. (05 Mar 2000) |
| mesocaval shunt | Anastomosis of the side of the superior mesenteric vein to the proximal end of the divided inferior vena cava, for control of portal hypertension, h-shunt anastomosis of the inferior vena cava to the superior mesenteric vein, using a synthetic conduit or autologous vein. (05 Mar 2000) |
| peritoneovenous shunt | An operation for the continuous emptying of ascitic fluid into the venous system. Fluid removal is based on intraperitoneal and intrathoracic superior vena cava pressure differentials and is performed via a pressure-sensitive one-way valve connected to a tube traversing the subcutaneous tissue of the chest wall to the neck where it enters the internal jugular vein and terminates in the superior vena cava. It is used in the treatment of intractable ascites. (12 Dec 1998) |
| right-to-left shunt | The passage of blood from the right side of the heart into the left (as through a septal defect), or from the pulmonary artery into the aorta (as through a patent ductus arteriosus); such a shunt can occur only when the pressure on the right side exceeds that in the left, as in advanced pulmonic stenosis, or when the pulmonary artery pressure exceeds aortic pressure, as in one form of Eisenmenger's syndrome or in tricuspid atresia. (05 Mar 2000) |
| Warburg-Dickens-Horecker shunt | <biochemistry> A pathway of hexose oxidation in which glucose-6-phosphate undergoes two successive oxidations by NADP, the final one being an oxidative decarboxylation to form a pentose phosphate. Diverges from this when glucose-6-phosphate is oxidized to ribose 5 phosphate by the enzyme glucose-6 phosphate dehydrogenase. This step reduces NADP to NADPH, generating a source of reducing power in cells for use in reductive biosyntheses. In plants, part of the pathway functions in the formation of hexoses from carbon dioxide in photosynthesis. Also important as source of pentoses, for example for nucleic acid biosynthesis. This pathway is the main metabolic pathway in neutrophils, congenital deficiency in the pathway produces sensitivity to infection. Alternative metabolic route to Embden Meyerhof pathway for breakdown of glucose. (18 Nov 1997) |
| Warburg-Lipmann-Dickens-Horecker shunt | <biochemistry> A pathway of hexose oxidation in which glucose-6-phosphate undergoes two successive oxidations by NADP, the final one being an oxidative decarboxylation to form a pentose phosphate. Diverges from this when glucose-6-phosphate is oxidized to ribose 5 phosphate by the enzyme glucose-6 phosphate dehydrogenase. This step reduces NADP to NADPH, generating a source of reducing power in cells for use in reductive biosyntheses. In plants, part of the pathway functions in the formation of hexoses from carbon dioxide in photosynthesis. Also important as source of pentoses, for example for nucleic acid biosynthesis. This pathway is the main metabolic pathway in neutrophils, congenital deficiency in the pathway produces sensitivity to infection. Alternative metabolic route to Embden Meyerhof pathway for breakdown of glucose. (18 Nov 1997) |
| Warren shunt | Anastomosis of the splenic end of the divided splenic vein to the left renal vein. Synonym: distal splenorenal shunt. (05 Mar 2000) |